Universal Biotech Innovation Prize is aiming to:

-acknowledge innovative talent and the development of new processes or products in the biotechnology industries sector

-allow those pro-active in International biotechnology industries and academic researcher to be brought together around a common objective –    excellence in the technical innovation and the development of bio-industries.

Evaluation criteria :

The innovations will be evaluated according to the following criteria:

      Scientific quality of the innovation

      Level of the intellectual property

      Quality of resources

      Project feasibility

      Chances of success on the market

Funding: € 100,000 plus one-year free services provided by Universal Medica Group

Deadline for proposals at VHIR. April, 5th 2012

Further information: Innovation Prize